Company News
05 Feb 2025
Lumos CEO Doug Ward and CFO Barrie Lambert present the Company's latest quarterly performance, highlighting strong revenue growth and key developments. The presentation covers recent achievements including BARDA funding for clinical trials, progress on major partnerships, and updates on product development initiatives, followed by a detailed Q&A session.
Take a look:
A few more pieces along the same thread. See the full index for everything.
COMPANY NEWS
1 min read
Lumos CEO Doug Ward, Lumos Chief Commercial Officer Paul Kase, Lumos Director of U.S. Sales
COMPANY NEWS
2 min read
FebriDx® has surpassed 100 healthcare locations across 18 states in the United States
COMPANY NEWS
1 min read
Lumos has achieved enrolment of 250 patients in its BARDA-funded FebriDx® paediatric clinical study, triggering a US$670,000 milestone payment...